Drug intelligence / Profile preview

[11C]BU99008

Development stage
Unknown
Lead developer
Imperial College London
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[11C]BU99008 is a radiolabeled positron emission tomography (PET) ligand specifically developed for imaging imidazoline2 binding sites (I2BS) in the brain. I2BS are believed to be expressed predominantly in glial cells and are implicated in the regulation of glial fibrillary acidic protein, with potential roles in neurodegenerative and neuroinflammatory diseases. [11C]BU99008 demonstrates high affinity and selectivity for I2BS, with minimal off-target binding to monoamine oxidase (MAO). It exhibits good brain penetration, reversible kinetics, heterogeneous distribution consistent with known I2BS expression patterns, and reliable test-retest reproducibility. The compound is used as a diagnostic radiopharmaceutical tool for research purposes to investigate alterations of I2BS expression in various neurological conditions[1][2][3][5].

Other names
Carbon-11 BU99008Carbon11 BU99008Carbon 11 BU9900811C-BU99008
02

Targets

I2R (Imidazoline I2 receptor)

Beyond the preview

Go deeper on [11C]BU99008.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [11C]BU99008.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call